Literature DB >> 15520186

Cooperative autocrine and paracrine functions of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in the progression of skin carcinoma cells.

Eva Obermueller1, Silvia Vosseler, Norbert E Fusenig, Margareta M Mueller.   

Abstract

Tumor growth and progression are critically controlled by alterations in the microenvironment often caused by an aberrant expression of growth factors and receptors. We demonstrated previously that tumor progression in patients and in the experimental HaCaT tumor model for skin squamous cell carcinomas is associated with a constitutive neoexpression of the hematopoietic growth factors granulocyte colony-stimulating factor (G-CSF) and granulocyte-macrophage colony-stimulating factor (GM-CSF), causing an autocrine stimulation of tumor cell proliferation and migration in vitro. To analyze the critical contribution of both factors to tumor progression, G-CSF or GM-CSF was stably transfected in factor-negative benign tumor cells. Forced expression of GM-CSF resulted in invasive growth and enhanced tumor cell proliferation in a three-dimensional culture model in vitro, yet tumor growth in vivo remained only transient. Constitutive expression of G-CSF, however, caused a shift from benign to malignant and strongly angiogenic tumors. Moreover, cells recultured from G-CSF-transfected tumors exhibited enhanced tumor aggressiveness upon reinjection, i.e., earlier onset and faster tumor expansion. Remarkably, this further step in tumor progression was again associated with the constitutive expression of GM-CSF strongly indicating a synergistic action of both factors. Additionally, expression of GM-CSF in the transfected tumors mediated an earlier recruitment of granulocytes and macrophages to the tumor site, and expression of G-CSF induced an enhanced and persistent angiogenesis and increased the number of granulocytes and macrophages in the tumor vicinity. Thus both factors directly stimulate tumor cell growth and, by modulating the tumor stroma, induce a microenvironment that promotes tumor progression.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15520186     DOI: 10.1158/0008-5472.CAN-03-3301

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  37 in total

Review 1.  Role of the β Common (βc) Family of Cytokines in Health and Disease.

Authors:  Timothy R Hercus; Winnie L T Kan; Sophie E Broughton; Denis Tvorogov; Hayley S Ramshaw; Jarrod J Sandow; Tracy L Nero; Urmi Dhagat; Emma J Thompson; Karen S Cheung Tung Shing; Duncan R McKenzie; Nicholas J Wilson; Catherine M Owczarek; Gino Vairo; Andrew D Nash; Vinay Tergaonkar; Timothy Hughes; Paul G Ekert; Michael S Samuel; Claudine S Bonder; Michele A Grimbaldeston; Michael W Parker; Angel F Lopez
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-06-01       Impact factor: 10.005

2.  Immature truncated O-glycophenotype of cancer directly induces oncogenic features.

Authors:  Prakash Radhakrishnan; Sally Dabelsteen; Frey Brus Madsen; Chiara Francavilla; Katharina L Kopp; Catharina Steentoft; Sergey Y Vakhrushev; Jesper V Olsen; Lars Hansen; Eric P Bennett; Anders Woetmann; Guangliang Yin; Longyun Chen; Haiyan Song; Mads Bak; Ryan A Hlady; Staci L Peters; Rene Opavsky; Christenze Thode; Klaus Qvortrup; Katrine T-B G Schjoldager; Henrik Clausen; Michael A Hollingsworth; Hans H Wandall
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-12       Impact factor: 11.205

3.  Hematopoietic derived cell infiltration of the intestinal tumor microenvironment in Apc Min/+ mice.

Authors:  Celestia Davis; Robert Price; Grishma Acharya; Troy Baudino; Thomas Borg; Franklin G Berger; Maria Marjorette O Peña
Journal:  Microsc Microanal       Date:  2011-04-08       Impact factor: 4.127

4.  Early prediction of tumor response to bevacizumab treatment in murine colon cancer models using three-dimensional dynamic contrast-enhanced ultrasound imaging.

Authors:  Jianhua Zhou; Huiping Zhang; Huaijun Wang; Amelie M Lutz; Ahmed El Kaffas; Lu Tian; Dimitre Hristov; Jürgen K Willmann
Journal:  Angiogenesis       Date:  2017-07-18       Impact factor: 9.596

5.  Autophagy promotes radiation-induced senescence but inhibits bystander effects in human breast cancer cells.

Authors:  Yao-Huei Huang; Pei-Ming Yang; Qiu-Yu Chuah; Yi-Jang Lee; Yi-Fen Hsieh; Chih-Wen Peng; Shu-Jun Chiu
Journal:  Autophagy       Date:  2014-04-30       Impact factor: 16.016

6.  Expression of CD163 prevents apoptosis through the production of granulocyte colony-stimulating factor in meningioma.

Authors:  Hiromi Kanno; Hiroshi Nishihara; Lei Wang; Sayaka Yuzawa; Hiroyuki Kobayashi; Masumi Tsuda; Taichi Kimura; Mishie Tanino; Shunsuke Terasaka; Shinya Tanaka
Journal:  Neuro Oncol       Date:  2013-03-28       Impact factor: 12.300

7.  RasGRP1 transgenic mice develop cutaneous squamous cell carcinomas in response to skin wounding: potential role of granulocyte colony-stimulating factor.

Authors:  Federico R Diez; Ann A Garrido; Amrish Sharma; Courtney T Luke; James C Stone; Nancy A Dower; J Mark Cline; Patricia S Lorenzo
Journal:  Am J Pathol       Date:  2009-06-04       Impact factor: 4.307

8.  MMP13 as a stromal mediator in controlling persistent angiogenesis in skin carcinoma.

Authors:  Wiltrud Lederle; Bettina Hartenstein; Alice Meides; Heike Kunzelmann; Zena Werb; Peter Angel; Margareta M Mueller
Journal:  Carcinogenesis       Date:  2009-11-05       Impact factor: 4.944

9.  Inducible cutaneous inflammation reveals a protumorigenic role for keratinocyte CXCR2 in skin carcinogenesis.

Authors:  Christophe Cataisson; Rebecca Ohman; Gopal Patel; Andrea Pearson; Margaret Tsien; Steve Jay; Lisa Wright; Henry Hennings; Stuart H Yuspa
Journal:  Cancer Res       Date:  2009-01-01       Impact factor: 12.701

10.  Anti-Inflammatory Drug Use and Ovarian Cancer Risk by COX1/COX2 Expression and Infiltration of Tumor-Associated Macrophages.

Authors:  Mollie E Barnard; Jonathan L Hecht; Megan S Rice; Mamta Gupta; Holly R Harris; A Heather Eliassen; Bernard A Rosner; Kathryn L Terry; Shelley S Tworoger
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2018-10-30       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.